Aurinia Pharmaceuticals Inc (AUPH)

[Jesspro]

Yes, indeed. He was in rare form, so overconfident. Wow, 45 business days or less, the FDA will give us the answer if it’s a go or not. With the p3 trial data producing a p-value of -.001, how could the FDA say no to it. It not only benefits the patients but the overall cost of treatiing LN. Greenleaf is not in favor of partnering the drug with big pharma. He said they will commercialize it but will have open ears if other parties express interest on it.